How many humira injections are needed for crohn's?

See the DrugPatentWatch profile for humira

How many Humira injections are needed for Crohn’s?

Most adults start with a loading phase of 160 mg on day 1, followed by 80 mg two weeks later. After that, the usual maintenance dose is 40 mg every other week. Some patients stay on this schedule for years while others switch to weekly 40 mg injections if symptoms flare.

When does the dose change during treatment?

Doctors often increase frequency to weekly if the every-other-week schedule stops working. They may also shorten the interval between injections or raise the dose to 80 mg weekly for severe cases. Dose changes are guided by symptom control and blood tests rather than a fixed calendar.

Can children follow the same schedule?

Children weighing 40 kg or more use the adult loading doses. Younger or lighter children receive weight-based doses, typically 20 mg or 40 mg every other week after the initial injections. Pediatric gastroenterologists adjust the plan based on growth and response.

What happens if a dose is missed?

A missed injection should be taken as soon as remembered, then the next dose follows the original schedule. Taking two doses too close together increases infection risk, so patients are advised to call their doctor for guidance rather than guessing.

How long do patients stay on Humira?

Treatment duration varies. Some people reach remission within months and continue injections for maintenance. Others stop after surgery or switch to another therapy if antibodies develop. Regular follow-up with a gastroenterologist determines when to taper or discontinue.

Who makes Humira and when does its patent expire?

AbbVie manufactures the original Humira. The main U.S. composition-of-matter patent expired in 2016, but market exclusivity through settlements ended in 2023. Biosimilar versions are now available, which may affect future pricing and insurance coverage.

How much does treatment cost with and without insurance?

List price for one 40 mg pen exceeds $6,000. With commercial insurance or AbbVie’s copay card, many patients pay $5 or less per dose. Medicare and Medicaid coverage varies by plan, and biosimilars often carry lower out-of-pocket costs.